Factor VIIa regulates the expression of caspase-3, MMP-9, and CD44 in SW620 colon cancer cells involving PAR2/MAPKs/NF-κB signaling pathways

Cancer Investigation

Volumn 31, Issue 1, 2013, Pages 7-16

  Wu, Ying ^a   Zhang, Xianmei ^b   Zhou, Hong ^b   Chen, Dongdong ^b   Xie, Hongxiang ^b   Mu, Yuan ^b   Wu, Biao ^b   Yan, Jinchuan ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Caspase 3MMP 9; CD44; Factor VIIa; Protease activated receptor 2; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7A; CASPASE 3; GELATINASE B; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE ACTIVATED RECEPTOR 2;

ARTICLE; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIGENS, CD44; CASPASE 3; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; DOWN-REGULATION; FACTOR VIIA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTOR, PAR-2; SIGNAL TRANSDUCTION;

EID: 84872725182     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.743556     Document Type: Article

References (33)

1. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N, Luger TA, Hollenberg MD. Proteinaseactivated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 2005;26:1-43 (Pubitemid 40209385)
2. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase activated receptors. Pharmacol Rev 2001;53:245-282
3. Kirkland JG, Cottrell GS, Bunnett NW, Corvera CU. Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder. Am J Physiol Gastrointest Liver Physiol 2007;293:G335-G346 (Pubitemid 47105197)
4. Bushell T. The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders. J Physiol 2007;581:7-16 (Pubitemid 46712024)
5. Zhou H, Hu H, Shi W, Ling S, Wang T, Wang H. The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells. Oncol Rep 2008;20:1069-1076
6. Zhou H, Shi W, Zhou B, Guo D, Wang T. Tissue factor-factor VIIa regulates interleukin-8, tissue factor and caspase-7 expression in SW620 cells through protease-activated receptor-2 activation. Mol Med Rep 2010;3:269-274
7. Guo D, Zhou H, Wu Y, Zhou F, Xu G, Wen H, Zhang X. Involvement of ERK1/21/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620. Tumor Biol 2011;32:921-930
8. Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI Coomber BL, Mackman N, Rak JW. Oncogenic events regulate tissue factor expression in colorectal cancer cells: Implications for tumor progression and angiogenesis. Blood 2005;105:1734-1741 (Pubitemid 40223697)
9. Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 2004;53:153-159
10. DanieleA, ZitoAF, GiannelliG,Divella R,AsseltiM,Mazzocca A Paradiso A, Quaranta M. Expression of metalloproteinases MMP- 2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer. Anticancer Res 2010;30:3521-3527
11. Peng ST, Su CH, Kuo CC, Shaw CF,WangHS. CD44 crosslinkingmediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis. Int JOncol 2007;31:1119-1126
12. Marutsuka K, Hatakeyama K, Sato Y, Yamashita A, Sumiyoshi A Asada Y. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cellmigration induced by tissue factor/factor VIIa complex. Thromb Res 2002;107:271-276 (Pubitemid 35435387)
13. Ruf W. Tissue factor and PAR signaling in tumor progression. Thromb Res 2007;120(suppl 2):S7-S12 (Pubitemid 350101768)
14. Awasthi V,Mandal SK, Papanna V, Rao LV, Pendurthi UR.Modulation of tissue factor-factorVlla signaling by lipid rafts and caveolae. ArteriosclerThromb Vasc Biol 2007;27:1447-1455 (Pubitemid 46809437)
15. Schaffner F, Ruf W. Tissue factor and PAR2 signaling in the tumor microenvironment. Arterioscler Thromb Vasc Biol 2009;29:1999-2004
16. Sørensen BB, Freskg̊ard PO, Nielsen LS, Rao LV, Ezban M, Petersen LC. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J Biol Chem 1999;274:21349-21354
17. Zerbib P, Grimonprez A, Corseaux D, Mouquet F, Nunes B, Petersen LC, Susen S, Ung A, Hebbar M, Pruvot FR, Chambon JP, Jude B. Inhibition of tissue factor-factor VIIa proteolytic activity blunts hepatic metastasis in colorectal cancer. J Surg Res 2009;153:239-245
18. Hector S, Prehn J. Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: A review. Biochim Biophys Acta 2009;1795:117-129
19. Groblewska M, Mroczko B, Szmitkowski M. The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development. Postepy Hig Med Dosw 2010;64:22-30
20. Du L, Wang H, He L, Zhang J, Ni B, Wang X, Jin H, Cahuzac N, Mehrpour M, Lu Y, Chen Q. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 2008;14: 6751-60
21. Åberg M, Wickström M, Siegbahn A. Simvastatin induces apoptosis in human breast cancer cells in a NFκB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa. Thromb Res 2008;122:191-202 (Pubitemid 351754915)
22. Sorensen BB, Rao LV, Tornehave D, Gammeltoft S, Petersen LC. Antiapoptotic effect of coagulation factor Vlla. Blood 2003;102:1708-1715 (Pubitemid 37022564)
23. Hahn N, Heiden M, Seitz R, Salge-Bartels U. Inducible expression of tissue factor in small-cell lung cancer: Impact on morphology and matrix metalloproteinase secretion. J Cancer Res Clin Oncol 2012;138:695-703
24. Xue M, Chan YK, Shen K, Dervish S, March L, Sambrook PN JacksonCJ. Protease activated receptor (PAR) 2, rather than PAR1 contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum 2012;64:88-98
25. Suen JY, Gardiner B, Grimmond S, Fairlie DP. Profiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cells. PLoS One 2010;5:e13809
26. McCoy KL, Traynelis SF, Hepler Jr. PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.Mol Pharmacol 2010;77:1005-1015
27. Lim JW, Kim H. Role of protease-activated receptor-2 on cell death and DNA fragmentation in Helicobacter pylori-infected gastric epithelial cells. J Transl Med 2010;8:85-92
28. Wang S, Quang LT, Chida J, Cisse Y, Yano M, Kido H. Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection. J Med Invest 2010;57:26-34
29. Itatsu K, Sasaki M, Harada K, Yamaguchi J, Ikeda H, Sato Y, Ohta T, Sato H, Nagino M, Nimura Y, Nakanuma Y. Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-kappaB are involved in upregulation of matrix metalloproteinase- 9 by tumor necrosis factor-alpha. Liver Int 2009;29: 291-298
30. Robbins EW, Travant EA, Yang K, Iczkowski KA. MAP kinase pathways and calcitonin influence CD44 alternate isoformexpression in prostate cancer cells. BMC Cancer 2008;8:260-269
31. Barry GD, Suen JY, Le GT, Cotterell A, Reid RC, Fairlie DP. Novel agonists and antagonists for human protease activated receptor 2
32. J Med Chem 2010;53:7428-7440
33. Suen JY, Barry GD, Lohman RJ, Halili MA, Cotterell AJ, Le GT Fairlie DP. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110). Br J Pharmacol 2012;165:1413-1423